Clinical Trial Update: Phase 1b of ASLAN001 (Varlitinib) in Patients With Advanced/ Metastatic Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1b/Phase 2 clinical trial evaluating varlitinib (ASLAN001) in advanced or metastatic hepatocellular carcinoma is ongoing, with current status not disclo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Varlitinib (varlitinib)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Advanced/ Metastatic Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN